187 related articles for article (PubMed ID: 31073966)
1. Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery.
Verhaak E; Gehring K; Hanssens PEJ; Sitskoorn MM
J Neurooncol; 2019 Jul; 143(3):537-546. PubMed ID: 31073966
[TBL] [Abstract][Full Text] [Related]
2. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life after Gamma Knife radiosurgery in patients with 1-10 brain metastases.
Verhaak E; Schimmel WCM; Gehring K; Emons WHM; Hanssens PEJ; Sitskoorn MM
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1157-1167. PubMed ID: 33025282
[TBL] [Abstract][Full Text] [Related]
4. Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
Sheehan JP; Grills I; Chiang VL; Dong H; Berg A; Warnick RE; Kondziolka D; Kavanagh B
J Neurosurg; 2018 Dec; 131(6):1848-1854. PubMed ID: 30579284
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in adult patients with brain metastases after stereotactic radiosurgery: a systematic, narrative review.
Verhaak E; Gehring K; Hanssens PEJ; Aaronson NK; Sitskoorn MM
Support Care Cancer; 2020 Feb; 28(2):473-484. PubMed ID: 31792879
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
Bunevicius A; Lavezzo K; Shabo L; McClure J; Sheehan JP
J Neurosurg; 2020 Jul; 134(6):1791-1799. PubMed ID: 32650308
[TBL] [Abstract][Full Text] [Related]
7. Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery.
Verhaak E; Schimmel WCM; Sitskoorn MM; Bakker M; Hanssens PEJ; Gehring K
J Neurooncol; 2019 Sep; 144(2):377-384. PubMed ID: 31350667
[TBL] [Abstract][Full Text] [Related]
8. Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.
Skeie BS; Eide GE; Flatebø M; Heggdal JI; Larsen E; Bragstad S; Pedersen PH; Enger PØ
J Neurosurg; 2017 Mar; 126(3):708-725. PubMed ID: 27058206
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
[TBL] [Abstract][Full Text] [Related]
10. Cognitive functioning and predictors thereof in patients with 1-10 brain metastases selected for stereotactic radiosurgery.
Schimmel WCM; Gehring K; Hanssens PEJ; Sitskoorn MM
J Neurooncol; 2019 Nov; 145(2):265-276. PubMed ID: 31552588
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
12. Health related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review.
Bunevicius A; Donovan L; Sheehan J
J Neurooncol; 2022 Sep; 159(2):319-331. PubMed ID: 35788469
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
14. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
15. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
16. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
Yomo S; Hayashi M
BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery in elderly patients with brain metastases: comparison with non-elderly patients using database of a multi-institutional prospective observational study (JLGK0901-Elderly).
Higuchi Y; Yamamoto M; Serizawa T; Sato Y; Shuto T; Akabane A; Jokura H; Yomo S; Nagano O; Kawagishi J; Yamanaka K; Aoyama H
J Neurooncol; 2019 Sep; 144(2):393-402. PubMed ID: 31338786
[TBL] [Abstract][Full Text] [Related]
18. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
[TBL] [Abstract][Full Text] [Related]
19. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases.
Xu Z; Lee CC; Ramesh A; Mueller AC; Schlesinger D; Cohen-Inbar O; Shih HH; Sheehan JP
J Neurosurg; 2017 Mar; 126(3):726-734. PubMed ID: 27203149
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life after stereotactic radiosurgery in patients with brain metastases.
Albers EAC; de Ligt KM; van de Poll-Franse LV; Compter A; de Ruiter MB; Schagen SB
Support Care Cancer; 2023 Nov; 31(12):720. PubMed ID: 38008876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
